Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9193 |
High Similarity |
NPD3818 |
Discontinued |
0.8868 |
High Similarity |
NPD3882 |
Suspended |
0.8861 |
High Similarity |
NPD2801 |
Approved |
0.8861 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8797 |
High Similarity |
NPD1934 |
Approved |
0.8788 |
High Similarity |
NPD7054 |
Approved |
0.8735 |
High Similarity |
NPD7074 |
Phase 3 |
0.8735 |
High Similarity |
NPD7472 |
Approved |
0.871 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8696 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8645 |
High Similarity |
NPD1511 |
Approved |
0.8599 |
High Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.859 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8589 |
High Similarity |
NPD5494 |
Approved |
0.858 |
High Similarity |
NPD7808 |
Phase 3 |
0.8571 |
High Similarity |
NPD6797 |
Phase 2 |
0.8571 |
High Similarity |
NPD3817 |
Phase 2 |
0.8535 |
High Similarity |
NPD1512 |
Approved |
0.8521 |
High Similarity |
NPD7251 |
Discontinued |
0.8521 |
High Similarity |
NPD6559 |
Discontinued |
0.8471 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8466 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8452 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8438 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8415 |
Intermediate Similarity |
NPD919 |
Approved |
0.8395 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8395 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8383 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8383 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8383 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8373 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8366 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8333 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8333 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8323 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8312 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8291 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.8272 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8258 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8258 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8224 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8204 |
Intermediate Similarity |
NPD1247 |
Approved |
0.8182 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8176 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8129 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8121 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8117 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8107 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.8095 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.8038 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8024 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7988 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7987 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7975 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7964 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7962 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7953 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7935 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7925 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7925 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7914 |
Intermediate Similarity |
NPD920 |
Approved |
0.7901 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7901 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7901 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7892 |
Intermediate Similarity |
NPD37 |
Approved |
0.7888 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7882 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7875 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7871 |
Intermediate Similarity |
NPD943 |
Approved |
0.787 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7857 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7857 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7857 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7844 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7805 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7798 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7791 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.774 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7736 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7727 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7709 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7707 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7692 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7688 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7683 |
Intermediate Similarity |
NPD5401 |
Approved |
0.768 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7673 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7673 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7651 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7628 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7628 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7627 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7605 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7605 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7597 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7594 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7584 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7562 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7557 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7557 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7547 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7546 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7546 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7539 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7516 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7516 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7514 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD2309 |
Approved |
0.75 |
Intermediate Similarity |
NPD8312 |
Approved |
0.75 |
Intermediate Similarity |
NPD8313 |
Approved |
0.75 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7469 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7453 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7436 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7429 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7421 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7421 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7419 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7407 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7407 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7407 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7407 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7407 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7407 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7407 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7353 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.7346 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7342 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.734 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.733 |
Intermediate Similarity |
NPD5710 |
Approved |
0.733 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7305 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7296 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7296 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7292 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7292 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7292 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7292 |
Intermediate Similarity |
NPD7698 |
Approved |
0.729 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7287 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7287 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7283 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7282 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7278 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7254 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7254 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7239 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7233 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7232 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7226 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7215 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7198 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7197 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7191 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7188 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7186 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7182 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7174 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.717 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7169 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7161 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7161 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.716 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7151 |
Intermediate Similarity |
NPD2403 |
Approved |
0.715 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7126 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7124 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7121 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7121 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7115 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7112 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7101 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7099 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7093 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7092 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7091 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7091 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7091 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7091 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7086 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7081 |
Intermediate Similarity |
NPD411 |
Approved |
0.7071 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7071 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7062 |
Intermediate Similarity |
NPD5005 |
Approved |
0.7062 |
Intermediate Similarity |
NPD5006 |
Approved |
0.7059 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7051 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7048 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7048
|
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |